https://x.com/Novavax/status/1815477517744021559

    What people need to know :

    1. COVID-19 Vaccine without mRNA Technology:

      • Novavax is known for its COVID-19 vaccine, which stands out because it doesn't rely on mRNA technology. This makes it a unique option in the market.
      • Many people in the USA and Europe eagerly await Novavax's vaccine, especially since it has already been selected for vaccination campaigns in countries like France.
    2. Matrix-M: A Game-Changing Vaccine Adjuvant:

      • Novavax's success isn't solely tied to its COVID-19 vaccine. The real game-changer is Matrix-M, a patented vaccine adjuvant.
      • Matrix-M is a cutting-edge biotech innovation that will play a crucial role in future vaccines.
      • Sanofi, a major pharmaceutical company, has even signed a contract with Novavax to use Matrix-M in their upcoming flu and COVID vaccines.
      • This positions Novavax as a company with significant potential for future royalties.
    3. Malaria Vaccine R21/Matrix-M:

      • Novavax's collaboration extends beyond COVID-19. They're part of a groundbreaking malaria vaccine project.
      • The R21/Matrix-M vaccine, developed jointly by Oxford University, Serum Institute of India, and Novavax, boasts an impressive efficacy rate of 77%.
      • For the first time, we have two vaccines available to combat malaria, a disease responsible for over 600,000 deaths annually (with 80% of victims being children under 5).
      • In 2025, up to 100 million people could receive this vaccine, marking a significant step forward in global health.
    4. Investment Outlook:

      • Novavax's stock is poised for growth. While it may not reach the astronomical heights seen during the COVID frenzy (200++++), it's still promising.
      • Expect gradual increases: from $25-$30 (maximum by September), to $35-$40 (December 2024), and potentially $50-$100 (within 12 months).

    Novavax (NVAX) about to skyrocket again. New and unique Malaria vaccine with 77% of efficacy !
    byu/lordtaylof inwallstreetbets



    Posted by lordtaylof

    30 Comments

    1. Defender_547 on

      Yes, my dear Novavax gave me 12 baggers last time. Finally, someone else talking about it.

    2. Huge_Philosopher5580 on

      I just look at the volume and it looks like a whale is trying to sneak in unnoticed.

      Compare it to the activity before the run up, it was nothing but bag holders.

      Anyways I’ve got long dated calls 1/16/26 30C

      First big (for me) bet in a long time. See yall on the other side.

    3. Plane_Vacation6771 on

      lol a vaccine that will have to be given away for free to the people who need it since they can’t pay for it…. sounds like a good buy.

    4. Kooky_Lime1793 on

      JFC what the hell happened the first week of June ? Some big candles green and red

    5. Future-Back8822 on

      1st world regards will opt to take the psychadyllic dream inducing horse pills

      There’s no money in 3rd world countries where malaria thrives

    6. EuphoricWizard on

      As someone with a PhD in this shit.  Matrix M is just a chemical called quillaja saponaria.  It’s grown in 3rd world dumpsters.  They do not own the rights to it.  It’s cheap to manufacture and sell, not patented.  

      Malaria mostly affects Africans.  You can’t make much money charging $0.1/dose to them.  

      Nothing listed drives any actual profits.  You need something that affects first world countries, specifically the US where the money is.  Weight loss drugs will be unmatched in revenue

    7. NuclearPopTarts on

      “Globally in 2022, there were an estimated 249 million malaria cases and 608 000 malaria deaths in 85 countries . . . Children under 5 accounted for about 80% of all malaria deaths in the Region.”

      If Novavax’s vaccine works, it will be one of the greatest advances in medicine in decades.

    8. This is awesome, I’m just not sure how much vaccines add to company value. In this case it may be showing potential for treatment approach though, so I hope it hits huge.

    9. It’s not just the only one without mRNA, it’s also the covid vaccine with highest efficacy and least side effects.

    10. Used_Principle_941 on

      That part of the world also suffers from vaccine hesitancy. They literally won’t get them, even if they are free.

      If the tech can be applied to other vaccines, then it may be worth something.

    11. Mysterious-Joke-2266 on

      Holy smokes i just looked at the 5 year chart. Some folks made an absolute fortune and there are some big bag holders

      My concern that is yes the malaria vaccine is good but profit wise, I know someone will pay for it like an NGO or even some governments but what kind of actual rollout can be expected.

      If their process for future vaccines can be sued theb yeh there is value.

      To rise by 10 bucks though in 2 months? Hard to see it yet

    Leave A Reply
    Share via